Commentary: how the doctor can counter commercial bias in the dissemination of pharmacotherapeutic knowledge.
D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use; D002986:Clinical Trials as Topic / Q000592:standards / Q000706:statistics & numerical data; D004059:Diffusion of Innovation; D004345:Drug Industry / Q000379:methods / Q000592:standards*; D004346:Drug Information Services; D004358:Drug Therapy / Q000379:methods / Q000592:standards*; D064420:Drug-Related Side Effects and Adverse Reactions; D006801:Humans; D001523:Mental Disorders / Q000188:drug therapy; D010818:Practice Patterns, Physicians' / Q000592:standards; D017594:Publication Bias; D012107:Research Design / Q000592:standards; D012109:Research Support as Topic / Q000379:methods / Q000592:standards; D012559:Schizophrenia / Q000188:drug therapy
D014150:Antipsychotic Agents